DCVC

Auradinescalability, sustainability and security solutions for the infrastructure, enabled by revolutionary blockchain, security, zero-knowledge and AI technologies.

Ascend supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.

Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.

MyNinja.ai is your SuperGPT AI Assistant Get tasks done using state-of-the-art AI agents and the world's best LLMs for $10/month OUR MISSION: Make everyone more productive by democratizing access to the best AI agents and foundational models in the world.

Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, established in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. By employing novel techniques, Evonetix aims to synthesize DNA with higher accuracy and scale, which enhances accessibility for researchers. This platform enables scientists to utilize synthetic biology on a previously unattainable scale, fundamentally changing how DNA is accessed, produced, and utilized for gene synthesis. The engineering team at Evonetix boasts extensive experience in creating high-integrity automated systems, bringing together a diverse range of expertise from various scientific and engineering disciplines to support its mission.

Auron Therapeutics is a biotechnology company based in Wellesley, Massachusetts, dedicated to developing innovative therapies for cancer. Founded in 2018, the company aims to transform the treatment paradigm by shifting from traditional cell-killing approaches to differentiation therapy, which seeks to convert malignant cells into normal functioning cells. This strategy reactivates the body's inherent cellular programs to promote tumor maturation and restore normal tissue. Auron Therapeutics utilizes advanced platforms that integrate large omic datasets with high-throughput flow cytometry, enabling the rapid identification and validation of multiple therapeutic targets and drugs using primary human patient samples. Through its research, the company aspires to address unmet medical needs in oncology and provide life-saving treatments for cancer patients.

Twelve, formerly known as Opus 12, is a Berkeley, California-based company that specializes in recycling carbon dioxide emissions into valuable chemicals and fuels. Founded in 2015, the company has developed innovative technology that can be integrated with any source of CO₂ emissions. By utilizing only water and electricity as inputs, Twelve transforms captured carbon dioxide into essential products such as methane, ethylene, and ethanol. The firm aims to provide a cost-competitive alternative to petroleum-derived chemicals and fuels, thereby addressing carbon emissions while simultaneously creating economically viable solutions.

Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.

Zap Energy, Inc. is a Seattle-based company incorporated in 2017 that specializes in the design and manufacture of sheared-flow stabilized Z-Pinch fusion reactors for power plants. The company's innovative approach stabilizes plasma using sheared flows instead of traditional magnetic fields, which allows for the creation of a magnetic field through electric current. This method effectively confines and compresses the plasma, resulting in higher pressure and density. Zap Energy aims to provide a low-carbon, cost-effective, and flexible energy solution through its compact and scalable fusion reactor technology, positioning itself as a leader in the pursuit of commercially viable fusion energy.

Sickbay, developed by Medical Informatics Corp., is a software platform designed to enhance patient monitoring and analytics in healthcare settings. It archives, aggregates, and transforms high-resolution waveform data from various medical devices, enabling real-time access and analysis of patient information. The platform supports continuous data collection and employs machine learning and artificial intelligence to deliver predictive analytics that facilitate data-driven medicine and patient-centered care. Sickbay also addresses alarm management by reducing alarm noise and ensuring that relevant alerts reach care providers. This comprehensive approach assists doctors, nurses, hospital administrators, and medical researchers in making informed decisions to improve patient outcomes. Founded in 2010 and headquartered in Houston, Texas, Medical Informatics Corp. aims to provide innovative solutions that enhance the efficiency and effectiveness of healthcare delivery.

They are developing a next-generation radioisotope power system that converts the heat from recycled nuclear waste into electricity.Their novel fuel and shielding design results in a system that is lightweight, cost-effective, and provides always-on, resilient power for years at a time.

Capella Space is a San Francisco-based company specializing in commercial radar satellite technology. It operates a constellation of small satellites that utilize synthetic aperture radar to capture high-resolution images of the Earth's surface, achieving clarity even in challenging conditions such as clouds, smoke, and darkness. The imagery provided is sub-meter in resolution and serves various industries, including defense, disaster response, agriculture, and infrastructure monitoring. By offering timely and flexible access to critical geospatial information, Capella Space enhances decision-making related to commerce, conservation, and public safety. Founded in 2014, the company aims to make Earth observation an integral tool for understanding and addressing the dynamic changes occurring globally.

Agility Robotics Inc. is a robotics development company founded in 2015 and based in Albany, Oregon. It specializes in designing and developing bipedal robots, notably Cassie, which is capable of walking and running. The company leverages its expertise in legged locomotion, rooted in extensive academic research, to create robots that serve as mobile sensor platforms and can operate in real-world environments. Agility Robotics aims to produce efficient, agile, and robust mobility solutions that can work alongside humans in various settings, such as offices, factories, and homes. Its technology enables clients to automate tasks in diverse terrains with minimal programming, addressing the practical needs of academic, corporate, and military sectors.

Unlearn is a San Francisco-based company founded in 2017 that specializes in using artificial intelligence to enhance clinical research. It develops innovative software tools aimed at improving clinical trial design, including the creation of Digital Twins to generate Intelligent Control Arms. By utilizing historical datasets and disease-specific machine-learning models, Unlearn produces virtual placebo patients derived from actual patient baseline data, which helps to increase trial power, accelerate timelines, and provide patient-level insights. This approach reduces or eliminates the need for concurrent control arms in clinical studies, streamlining the research process. Unlearn has garnered significant attention, securing $20 million in funding and collaborating with leading pharmaceutical companies. Its work has been recognized in prestigious publications, including a peer-reviewed article in Nature, and it has been acknowledged as a key player in digital health innovation. The company continues to engage with regulators and industry leaders to drive advancements in clinical research through the application of AI technologies.

Aclarity, LLC is a manufacturer of innovative water purification devices aimed at improving water treatment processes for residential use. Founded in 2017 and headquartered in the United States, the company leverages patent-pending electrochemical technology to effectively remove a wide range of contaminants, including pathogens, metals, volatile organic compounds (VOCs), per- and polyfluoroalkyl substances (PFAS), and ammonia from water. Aclarity's systems are designed to provide cost-effective, low-maintenance solutions, ensuring comprehensive purification while promoting safe and clean water for its customers and end-users.

zkLend is a Layer 2 money-market protocol developed on StarkNet, designed to enhance financial transactions through the use of zk-rollup technology. This decentralized platform leverages Ethereum's security while offering superior transaction speed and cost efficiency. By combining these advantages, zkLend enables users to conduct transactions securely and privately, making it an attractive option for those seeking to engage in decentralized finance.

Brimstone Energy is a hardware cleantech startup that aims to reduce CO2 emissions through innovative technologies.

Plotlogic Pty Ltd is a Brisbane-based company that specializes in developing advanced ore characterization systems for the mining industry. The firm employs hyperspectral imaging technology through its flagship product, OreSense LV, which identifies variations in a mine's geological model. Additionally, it offers OreBlocks, an API designed to enhance planning processes, and OreCheck, which provides real-time alerts regarding material variations. The technology aims to improve ore recovery and minimize dilution while also reducing carbon emissions and operational costs. Plotlogic's systems are applicable to various commodities, including coal, iron ore, and gold. Founded in 2005, the company is dedicated to offering customized support services alongside its innovative solutions.

Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.

Operator of a fully managed cloud service platform intended to provide data analytics for event streaming. The company's platform has been deployed for key applications at always-on businesses that require real-time action on event-based data, such as e-commerce sites, digital marketing platforms, and service marketplaces, enabling its users to analyze and optimize the data and share it with their colleagues and external partners using their email addresses.

Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Petra is a Robotics company that focuses solely on underground utilities. Petra enables undergrounding critical utilities by boring utility tunnels through previously impenetrable geologies.

Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's technology uses the power of covalent bonding and a proprietary technology platform for high-throughput drug discovery, enabling pharmaceutical developers to convert genetic discoveries into real drugs to treat cancer, Alzheimer's, infectious diseases, and even aging.

Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.

Kettle Inc. is an innovative company based in Kensington, California, specializing in online risk analysis for the insurance industry. Founded in 2020, Kettle develops a machine-learning powered platform that utilizes deep learning algorithms to analyze over seven billion lines of satellite, weather, and ground truth data. By employing Swarm Neural Networks, the platform identifies patterns that enhance the accuracy of risk predictions related to climate change, thereby assisting insurers in managing catastrophic risks. Kettle's approach aims to improve underwriting processes and reduce loss ratios, enabling the sale of reinsurance to other insurers while effectively balancing risk in an evolving climate landscape.

nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

Gradle, Inc. is a developer of open-source build automation software that aims to transform the software development process. The Gradle Build Tool is widely recognized as the most popular build tool for open-source JVM projects, averaging over 19 million downloads monthly and being utilized by notable projects such as Spring Boot and JUnit. Gradle Enterprise complements this by providing a software build performance acceleration and analytics platform, designed to enhance productivity for software development teams. This self-hosted solution utilizes advanced acceleration technologies to reduce build times significantly and employs data analytics for efficient troubleshooting. Gradle Enterprise supports the discipline of Developer Productivity Engineering, enhancing the build and test processes within both Gradle and Maven environments. By unifying and automating build processes, Gradle, Inc. enables enterprises to improve their software delivery capabilities effectively.

StarkWare Industries Ltd, founded in 2017 and based in Netanya, Israel, specializes in developing software and hardware for generating and verifying computational integrity proofs. The company has created STARK, a zero-knowledge proof protocol that enhances scalability and privacy in blockchain applications. This technology allows for increased transaction throughput and enables off-chain computation while ensuring that sensitive underlying data remains confidential. StarkWare's solutions are designed to improve the efficiency, security, and overall user experience of blockchain systems, making them a key player in the field of cryptographic proof platforms.

Jupiter Intelligence, Inc. specializes in developing tools and platforms that provide comprehensive weather and climate data, trend visualizations, forecasts, and risk assessments. The company offers the ClimateScore Intelligence Platform, which utilizes cloud computing to integrate multiple prediction models based on data from millions of ground-based and satellite sensors. Additionally, Jupiter provides FloodScore and HeatScore services, which help users prepare for flooding and mitigate temperature-related impacts from climate change, respectively. These services focus on climate risk assessment and management in urban regions such as New York City, South Florida, and the Atlantic Coast, with plans for global expansion. Jupiter's models are informed by the latest scientific research from the global Earth and Ocean Systems community. Founded in 2017 and based in San Mateo, California, Jupiter Intelligence was previously known as Jupiter Technology Systems, Inc. before rebranding in December 2017.

TrustPoint is developing a next-generation GPS signal processing technology to provide the performance and reliability required for safety-critical automation, vital infrastructure, and seamless augmented reality.

Kentik Technologies, Inc. is a network intelligence platform that delivers cloud-based real-time visibility and analytics solutions for network and security operators. Founded in 2014 and headquartered in San Francisco, California, the company offers Kentik Detect, a big data-based software-as-a-service that transforms network data into actionable intelligence. This platform enables clients to conduct ad-hoc analytics for improved operations, capacity optimization, anomaly resolution, and DDoS detection, thereby enhancing application and service protection. Kentik also provides My Kentik, a self-service network analytics tool, and an AIOps platform aimed at streamlining network operations. Additionally, the company serves various industries, including financial services, media and entertainment, cloud infrastructure, and telecommunications, offering tailored solutions for visibility, performance, detection, planning, and integration. Kentik was previously known as CloudHelix, Inc. before rebranding in September 2014.

CH4 Global Inc. is a holding company based in San Francisco, California, that specializes in producing seaweed bio-products aimed at reducing methane emissions from livestock. Founded in 2019, the company focuses on Asparagopsis armata, a seaweed supplement that has been scientifically proven to decrease methane emissions from ruminant animals such as cows, goats, sheep, and deer by up to 90%. By leveraging advanced aquaculture techniques, CH4 Global provides innovative solutions to mitigate greenhouse gases on a global scale, with its products offered through subsidiaries in the United States, Australia, New Zealand, and the Pacific. The company has attracted investment from family offices and private investors, as well as support from government organizations, to further its mission of addressing climate change while providing benefits like carbon credits for farmers and food producers.

CodeSee is a developer of cloud-based data visualization software that facilitates a comprehensive understanding of code for developers and development teams. By analyzing the data flowing through a system, CodeSee creates an updated map of the system architecture, its components, and their interconnections. This allows developers to explore their codebase at both a high level and in detail, enhancing their ability to grasp how code and functionality relate to one another. The platform aims to transform developers from feeling like outsiders to becoming high performers, thereby expediting the development process and improving overall productivity.

GenEdit Inc. is a biotechnology company based in Berkeley, California, established in 2016. It specializes in developing innovative genome editing technologies, particularly using the CRISPR/Cas9 system for therapeutic gene editing. The company focuses on addressing the challenges associated with the delivery of gene therapies through its proprietary non-viral nanoparticle-based delivery platform. This platform enables more efficient and accurate delivery of CRISPR components, enhancing the potential for curative treatments for genetic diseases. By systematically screening a library of nanoparticles, GenEdit aims to improve the safety and effectiveness of gene editing, making it a promising solution for a wide range of therapeutic applications.

Kairos Aerospace provides large-scale, aerial monitoring of methane emissions. The company completed the first-ever basin-wide aerial survey for methane detection in its 2019 survey of the Permian Basin. Kairos Aerospace’s mission is to improve operational excellence for the oil and gas industry with cost-effective, efficient methane reductions at scale.

Earth AI Pty Ltd. is an innovative mineral exploration company based in Parramatta, Australia, founded in 2016. The company specializes in developing artificial intelligence-based software that identifies potential areas of mineralization in remote locations lacking pre-existing geological data. By using AI mineral targeting technology, Earth AI provides geologists with location suggestions for mineral exposure and automatically generates detailed geological maps from satellite, geophysical, and geochemical datasets. This approach allows Earth AI to discover new metal deposits valued between $10 million and $100 million significantly faster and at a lower cost than traditional methods. The company's field-proven system is reported to be 50 times more successful in identifying mineralized prospects and achieves five times cheaper field operations through hardware automation and streamlined processes. Earth AI focuses on various metals, including copper, lead, zinc, nickel, cobalt, vanadium, and rare earth elements, effectively enhancing the chances of successful mineral discovery while minimizing operational risks and expenses.

Developer of a desalination technique designed to solve the toxic brine problem that exists in desalination. The company's technology utilizes a solvent that, when heated attracts brine in high-salinity water separating it from freshwater, enabling organizations to reuse the solvent in subsequent cycles.

Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Frontier Medicines Corporation is a pre-clinical stage biopharmaceutical company based in South San Francisco, California, founded in 2018. The company specializes in discovering and developing medicines that target cancer-causing proteins through its innovative chemoproteomics platform. This platform utilizes advanced computational techniques and machine learning to identify new binding pockets on proteins, thereby facilitating the discovery and development of small-molecule drugs. By enhancing the drug development process, Frontier Medicines aims to deliver breakthrough therapies that can significantly change the treatment landscape for debilitating diseases.

Stemson Therapeutics, LLC operates as a cell therapy company that helps to restore natural hair. The company produces cells required to regenerate hair follicles using the novel cell engineering process. Its products include the stemson solution, a solution that generates novo follicles using induced pluripotent stem cells (iPSC) to grow new Dermal Papilla. The company was founded in 2018 and is based in LA Jolla, California.

Swift Medical Inc. is a Toronto-based company that specializes in wound care management through its mobile application, Swift. This application enables healthcare professionals to measure and document the progression of patients' wounds efficiently. By facilitating real-time sharing of wound images, Swift enhances communication among medical teams and ensures precise and consistent documentation. The platform is designed to provide comprehensive wound care solutions for healthcare enterprises, streamlining the process from initial assessment to ongoing treatment.

Twelve, formerly known as Opus 12, is a Berkeley, California-based company that specializes in recycling carbon dioxide emissions into valuable chemicals and fuels. Founded in 2015, the company has developed innovative technology that can be integrated with any source of CO₂ emissions. By utilizing only water and electricity as inputs, Twelve transforms captured carbon dioxide into essential products such as methane, ethylene, and ethanol. The firm aims to provide a cost-competitive alternative to petroleum-derived chemicals and fuels, thereby addressing carbon emissions while simultaneously creating economically viable solutions.

Primer Technologies, Inc. specializes in developing advanced software that employs machine learning and natural language processing to analyze extensive datasets. The company's platform is designed to read and interpret documents in multiple languages, uncover insights, and generate automated reports that rival human analysis. By facilitating the understanding of vast amounts of text data, Primer assists governments and corporations in monitoring and making sense of global information. Founded in 2015 and headquartered in San Francisco, California, Primer aims to bridge the intelligence gap for businesses and enhance their ability to respond to emerging trends in the world.

Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

StarkWare Industries Ltd, founded in 2017 and based in Netanya, Israel, specializes in developing software and hardware for generating and verifying computational integrity proofs. The company has created STARK, a zero-knowledge proof protocol that enhances scalability and privacy in blockchain applications. This technology allows for increased transaction throughput and enables off-chain computation while ensuring that sensitive underlying data remains confidential. StarkWare's solutions are designed to improve the efficiency, security, and overall user experience of blockchain systems, making them a key player in the field of cryptographic proof platforms.

Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

BioPhero ApS provides bio-based pheromones for pest management. The company was founded in 2016 and is based in Kongens Lyngby, Denmark.

Developer of a wildfire detection and intelligence platform intended to quickly mitigate wildfire threats. The company's platform uses artificial intelligence applied to proprietary mountaintop camera feeds and satellite imagery to detect threats in real-time from a monitoring system for confirmation and rapid dissemination of critical information, enabling government agencies, utilities, and private landowners to take action to protect lives, property, and the environment.

Plexium, Inc. is a biotechnology company based in San Diego, California, established in 2017. The company specializes in drug development, focusing on the identification of small molecules that modulate E3 ligases for therapeutic applications in cancer and neurodegenerative diseases. Plexium employs a DNA-encoded library platform to conduct high-throughput screening, utilizing cell-based assays to discover molecular glues that can alter E3 ligase substrate recognition, thereby inducing, inhibiting, or modulating protein degradation. This innovative approach allows Plexium to selectively target various cancers, including small cell lung and breast tumors, while also exploring mechanisms to enhance immune responses through E3 ligase modulation.

Gro Intelligence is a data analytics platform focused on the global agriculture industry, utilizing artificial intelligence and machine learning to analyze a wide range of agricultural data. Founded in 2014 and headquartered in New York, with an additional office in Nairobi, the company aggregates and processes both structured and unstructured data from diverse sources, including satellite imagery and trade reports. By employing proprietary algorithms, Gro Intelligence generates predictive models that provide insights into weather patterns, trade flows, pricing dynamics, and production metrics. This enables financial institutions, corporations, and public sector entities to make informed decisions based on comprehensive and timely information. The company has attracted significant investment, raising $20 million to date from notable investors. With approximately 50 employees, Gro Intelligence aims to bridge data gaps within the agricultural sector, enhancing productivity and access to capital for stakeholders across the ecosystem.

Deepcell, Inc. is a company based in Mountain View, California, focused on advancing diagnostic technologies through a non-invasive approach. Founded in 2015, it has developed a microfluidic imaging platform that leverages artificial intelligence to classify cells by their visual features. This technology allows for the isolation of viable cells based on their morphological characteristics, facilitating detailed genetic health assessments from standard blood samples. By enabling insights at the single-cell level, Deepcell aims to improve the diagnosis and treatment of various diseases, offering researchers a valuable alternative to invasive diagnostic methods.

Subtle Medical, Inc., a healthcare technology company, develops medical imaging software for clinical imaging centers and hospitals. Its product includes SubtleMR, an artificial intelligence-based image processing software that reduces image noise and increases image sharpness for non-contrast enhanced magnetic resonance imaging (MRI). It enables to reduce cost, imaging time, and radiation/contrast dose. The company was founded in 2017 and is based in Menlo Park, California.

Provider of immunotherapies intended to transform cancer treatment and improve quality of life. The company's cellular immunotherapy platform uses gene therapy to target cancer cells and delivers to any patient, with any tumor, at any time to directly, safely, and controllably attack cancer, enabling medical practitioners to safeguard patients by creating and harnessing a powerful immune response in the body.

Provider of immunotherapies intended to transform cancer treatment and improve quality of life. The company's cellular immunotherapy platform uses gene therapy to target cancer cells and delivers to any patient, with any tumor, at any time to directly, safely, and controllably attack cancer, enabling medical practitioners to safeguard patients by creating and harnessing a powerful immune response in the body.

MycoWorks LLC specializes in the research, design, and manufacturing of sustainable leather alternatives derived from natural mycelium. Established in 2013 and based in San Francisco, the company produces a proprietary material called Reishi, which is water-resistant and customizable in texture and features. Reishi is designed to mimic the performance and feel of traditional leather while being animal-free and environmentally friendly. MycoWorks employs a unique platform known as Fine Mycelium to create this innovative biomaterial, which boasts qualities such as strength, durability, and biodegradability. The company aims to provide natural alternatives to conventional materials like plastic foams, textiles, and leather, catering to industries such as aerospace, automotive, apparel, and architectural interiors. Through its carbon-negative production process, MycoWorks offers a rapidly grown solution that aligns with sustainable design principles.

Developer of a decentralized interoperability software designed to connect blockchain ecosystems and applications with users. The company's software is powered by byzantine consensus, cryptography, and mechanism design protocols that let applications live on different blockchains to communicate with each other, enabling users to get a distributed network, APIs, and tools to make it easy to build cross-chain decentralized applications.

Carbon Health is a tech-enabled healthcare company founded in 2015 and headquartered in San Francisco, California. It provides a mobile application that facilitates primary care services, allowing users to manage their treatment plans, prescriptions, and lab reports in one place. The company offers omnichannel care through various access points, including clinics, pop-up sites, video consultations, and its application, ensuring convenient and accessible healthcare for patients. Additionally, Carbon Health developed a coronavirus assessment tool and has established COVID-19 testing sites in California, further enhancing its commitment to delivering comprehensive healthcare services.

Unlearn is a San Francisco-based company founded in 2017 that specializes in using artificial intelligence to enhance clinical research. It develops innovative software tools aimed at improving clinical trial design, including the creation of Digital Twins to generate Intelligent Control Arms. By utilizing historical datasets and disease-specific machine-learning models, Unlearn produces virtual placebo patients derived from actual patient baseline data, which helps to increase trial power, accelerate timelines, and provide patient-level insights. This approach reduces or eliminates the need for concurrent control arms in clinical studies, streamlining the research process. Unlearn has garnered significant attention, securing $20 million in funding and collaborating with leading pharmaceutical companies. Its work has been recognized in prestigious publications, including a peer-reviewed article in Nature, and it has been acknowledged as a key player in digital health innovation. The company continues to engage with regulators and industry leaders to drive advancements in clinical research through the application of AI technologies.

Agility Robotics Inc. is a robotics development company founded in 2015 and based in Albany, Oregon. It specializes in designing and developing bipedal robots, notably Cassie, which is capable of walking and running. The company leverages its expertise in legged locomotion, rooted in extensive academic research, to create robots that serve as mobile sensor platforms and can operate in real-world environments. Agility Robotics aims to produce efficient, agile, and robust mobility solutions that can work alongside humans in various settings, such as offices, factories, and homes. Its technology enables clients to automate tasks in diverse terrains with minimal programming, addressing the practical needs of academic, corporate, and military sectors.

Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases.

Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler. It combines a powerful search across several entities with fine-grain alerts to stay on top of changes, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.

Curative is a healthcare provider focused on enhancing access to essential medical services. The company specializes in COVID-19 testing, offering a 24-hour service that utilizes a more efficient and precise oral fluid test, thereby alleviating strain on medical supply chains and healthcare workers. In addition to testing, Curative provides a range of services including vaccinations, baseline health visits, and virtual urgent care, all designed to facilitate easier access to healthcare for individuals. This commitment to improving healthcare accessibility positions Curative as a significant player in the health insurance sector, catering to the needs of diverse communities.

nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.

Operator of an online medical data platform intended to automate medical coding to build an actionable data layer for hospitals. The company's platform provides a disruptive data engine for medical data analysis to extract medical codes and insights from patient charts to create a longitudinal and real-time actionable data layer, enabling hospitals to improve patient care, efficiencies, and value-based care.

Auransa is an AI-driven platform for discovering drugs of novel pharmacology from vast amounts of genomics data collected from human disease tissues. The company's platform is used to study molecular disease subtypes and predict compounds and targets for responder patient population. Current internal drug pipeline includes cancer and other diseases. The company has partnership with companies and institutions in biopharma industry.

Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Rigetti Computing is a full-stack quantum computing company based in Berkeley, California, with an additional office in Fremont. Founded in 2013, it designs and manufactures quantum integrated circuits and superconducting quantum processors. The company packages and deploys these chips in low-temperature environments and develops accompanying control systems to perform quantum logic operations. Rigetti also offers a cloud services platform, Quantum, which facilitates the integration of its quantum machines into various cloud environments. Additionally, it provides Forest, a programming and execution environment that supports the development of quantum applications. With a focus on near-term applications in computational chemistry and machine learning, Rigetti aims to advance practical quantum computing through its proprietary technology and infrastructure, which enables seamless integration with both public and private cloud systems. The majority of its revenue is generated in the United States.

Caption Health, Inc. develops artificial intelligence-based software solutions designed to assist healthcare providers in acquiring and interpreting ultrasound exams. The company's flagship product, Caption AI, offers real-time guidance for performing echocardiography, enabling practitioners to capture diagnostic-quality images, automate quality assessments, and interpret ultrasound results effectively. Founded in 2013 and headquartered in Brisbane, California, Caption Health was previously known as Bay Labs, Inc. The company focuses on enhancing the capabilities of ultrasound technology through innovative software, ultimately aiming to improve patient outcomes in medical imaging.

Horizon Quantum Computing Pte. Ltd., established in 2018 and headquartered in Singapore, focuses on creating software development tools that facilitate the development of quantum software applications. The company's innovative tools aim to bridge the gap between quantum computing and conventional software development, allowing researchers to enhance their productivity. By utilizing abstraction techniques, Horizon's solutions enable software engineers to engage in quantum application development without requiring prior experience in quantum computing. This approach not only simplifies the development process but also broadens access to quantum-enhanced applications, contributing to advancements in the field of quantum technology.

Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases.

Proprio, Inc. is a Seattle-based healthcare technology company founded in 2016, specializing in next-generation surgical navigation and imaging solutions. The company develops a platform that integrates machine learning, automated intelligence, and mixed-reality user interfaces to enhance surgical accuracy and streamline workflows. By utilizing advanced technologies such as light field computer vision and depth-sensing capabilities, Proprio's system replaces traditional surgical microscopes, navigation systems, and loupes, offering a more immersive 3D environment for medical professionals. This innovative approach aims to improve patient outcomes while allowing for greater adaptability in surgical practices. Proprio's vision extends beyond mere technological upgrades; the company seeks to revolutionize the medical field by harnessing software development techniques, thereby enabling rapid innovation and a more integrated use of data and artificial intelligence in surgery.

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to these patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to these patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

AbCellera Biologics Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies. Founded in 2012 and headquartered in Vancouver, Canada, it has created a full-stack, AI-powered platform that analyzes natural immune systems to identify antibodies suitable for drug development. The company employs next-generation transgenic mice, which generate fully human antibodies, enhancing its ability to discover effective therapeutic candidates. AbCellera's innovative approach addresses the limitations of traditional antibody discovery by enabling faster and more precise identification of optimal clinical candidates. It has established partnerships with various pharmaceutical companies, including a significant collaboration with Eli Lilly and Company to explore multiple targets. Through its proprietary technologies and expertise, AbCellera aims to streamline the antibody discovery process and support the development of next-generation therapeutics.

AbCellera Biologics Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies. Founded in 2012 and headquartered in Vancouver, Canada, it has created a full-stack, AI-powered platform that analyzes natural immune systems to identify antibodies suitable for drug development. The company employs next-generation transgenic mice, which generate fully human antibodies, enhancing its ability to discover effective therapeutic candidates. AbCellera's innovative approach addresses the limitations of traditional antibody discovery by enabling faster and more precise identification of optimal clinical candidates. It has established partnerships with various pharmaceutical companies, including a significant collaboration with Eli Lilly and Company to explore multiple targets. Through its proprietary technologies and expertise, AbCellera aims to streamline the antibody discovery process and support the development of next-generation therapeutics.

Kentik Technologies, Inc. is a network intelligence platform that delivers cloud-based real-time visibility and analytics solutions for network and security operators. Founded in 2014 and headquartered in San Francisco, California, the company offers Kentik Detect, a big data-based software-as-a-service that transforms network data into actionable intelligence. This platform enables clients to conduct ad-hoc analytics for improved operations, capacity optimization, anomaly resolution, and DDoS detection, thereby enhancing application and service protection. Kentik also provides My Kentik, a self-service network analytics tool, and an AIOps platform aimed at streamlining network operations. Additionally, the company serves various industries, including financial services, media and entertainment, cloud infrastructure, and telecommunications, offering tailored solutions for visibility, performance, detection, planning, and integration. Kentik was previously known as CloudHelix, Inc. before rebranding in September 2014.

Carbon Health is a tech-enabled healthcare company founded in 2015 and headquartered in San Francisco, California. It provides a mobile application that facilitates primary care services, allowing users to manage their treatment plans, prescriptions, and lab reports in one place. The company offers omnichannel care through various access points, including clinics, pop-up sites, video consultations, and its application, ensuring convenient and accessible healthcare for patients. Additionally, Carbon Health developed a coronavirus assessment tool and has established COVID-19 testing sites in California, further enhancing its commitment to delivering comprehensive healthcare services.

Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Biobot Analytics, Inc. is a wastewater epidemiology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in transforming sewer systems into public health observatories through innovative technology that analyzes wastewater samples. By deploying proprietary sampling devices and spatial analytics, Biobot measures various health threats, including infectious disease outbreaks, antibiotic resistance, and fluctuations in drug consumption. One of its key initiatives is the Opioid Consumption Monitoring Program, which assesses opioid usage by analyzing sewage to provide estimates of drug consumption in urban areas. This approach creates a health database that operates independently of traditional hospital reporting systems, enabling rapid adaptation to emerging public health challenges while minimizing societal biases in healthcare access.

Unlearn is a San Francisco-based company founded in 2017 that specializes in using artificial intelligence to enhance clinical research. It develops innovative software tools aimed at improving clinical trial design, including the creation of Digital Twins to generate Intelligent Control Arms. By utilizing historical datasets and disease-specific machine-learning models, Unlearn produces virtual placebo patients derived from actual patient baseline data, which helps to increase trial power, accelerate timelines, and provide patient-level insights. This approach reduces or eliminates the need for concurrent control arms in clinical studies, streamlining the research process. Unlearn has garnered significant attention, securing $20 million in funding and collaborating with leading pharmaceutical companies. Its work has been recognized in prestigious publications, including a peer-reviewed article in Nature, and it has been acknowledged as a key player in digital health innovation. The company continues to engage with regulators and industry leaders to drive advancements in clinical research through the application of AI technologies.

Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

AbCellera Biologics Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies. Founded in 2012 and headquartered in Vancouver, Canada, it has created a full-stack, AI-powered platform that analyzes natural immune systems to identify antibodies suitable for drug development. The company employs next-generation transgenic mice, which generate fully human antibodies, enhancing its ability to discover effective therapeutic candidates. AbCellera's innovative approach addresses the limitations of traditional antibody discovery by enabling faster and more precise identification of optimal clinical candidates. It has established partnerships with various pharmaceutical companies, including a significant collaboration with Eli Lilly and Company to explore multiple targets. Through its proprietary technologies and expertise, AbCellera aims to streamline the antibody discovery process and support the development of next-generation therapeutics.

Culture Biosciences, founded in 2016 and headquartered in San Francisco, California, specializes in developing automated bioreactors and tools for fermentation. The company provides a digital bio-manufacturing platform that allows biotech companies to optimize their manufacturing processes, enabling them to bring products to market more efficiently. By utilizing robotic sample handling and cloud-based data monitoring and analysis, Culture Biosciences helps scientists run, monitor, and analyze bioreactors more quickly than traditional methods. This innovative approach supports the biotechnology sector in enhancing productivity and streamlining workflows.

Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, established in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. By employing novel techniques, Evonetix aims to synthesize DNA with higher accuracy and scale, which enhances accessibility for researchers. This platform enables scientists to utilize synthetic biology on a previously unattainable scale, fundamentally changing how DNA is accessed, produced, and utilized for gene synthesis. The engineering team at Evonetix boasts extensive experience in creating high-integrity automated systems, bringing together a diverse range of expertise from various scientific and engineering disciplines to support its mission.

C16 Biosciences, founded in 2017 and based in New York, specializes in developing sustainable alternatives to palm oil through microbial fermentation. The company addresses the environmental concerns associated with traditional palm oil production, which often involves deforestation and unethical labor practices. By using established fermentation processes, C16 Biosciences aims to provide food manufacturers, refiners, traders, and consumers with bio-based oils that reduce the ecological impact of palm oil. Their innovative approach allows producers to invest in sustainable practices, ultimately protecting natural resources and wildlife. C16 Biosciences' mission is to create a world where consumers can enjoy their favorite products without contributing to harmful environmental practices.

MycoWorks LLC specializes in the research, design, and manufacturing of sustainable leather alternatives derived from natural mycelium. Established in 2013 and based in San Francisco, the company produces a proprietary material called Reishi, which is water-resistant and customizable in texture and features. Reishi is designed to mimic the performance and feel of traditional leather while being animal-free and environmentally friendly. MycoWorks employs a unique platform known as Fine Mycelium to create this innovative biomaterial, which boasts qualities such as strength, durability, and biodegradability. The company aims to provide natural alternatives to conventional materials like plastic foams, textiles, and leather, catering to industries such as aerospace, automotive, apparel, and architectural interiors. Through its carbon-negative production process, MycoWorks offers a rapidly grown solution that aligns with sustainable design principles.

MycoWorks LLC specializes in the research, design, and manufacturing of sustainable leather alternatives derived from natural mycelium. Established in 2013 and based in San Francisco, the company produces a proprietary material called Reishi, which is water-resistant and customizable in texture and features. Reishi is designed to mimic the performance and feel of traditional leather while being animal-free and environmentally friendly. MycoWorks employs a unique platform known as Fine Mycelium to create this innovative biomaterial, which boasts qualities such as strength, durability, and biodegradability. The company aims to provide natural alternatives to conventional materials like plastic foams, textiles, and leather, catering to industries such as aerospace, automotive, apparel, and architectural interiors. Through its carbon-negative production process, MycoWorks offers a rapidly grown solution that aligns with sustainable design principles.

Advano, operating under NanoStar, Inc., is a New Orleans-based company specializing in silicon nanotechnology. Founded in 2014, Advano develops and produces functionalized silicon nanoparticles and quantum dots for various applications. Notably, its products enhance the energy density of lithium-ion batteries by 30-40%, making them suitable for electric vehicles, consumer electronics, and IoT devices, all without compromising battery life or increasing costs. Additionally, Advano's technology is applied in CO2 carbon capture, super hydrophobic coatings, and printable electronics, serving industries such as telecommunications.

Empirico is a company focused on developing an insights platform that leverages biological insights derived from human genetics to create new medicines. Its platform utilizes biological datasets and programmable biology to facilitate target discovery and development. This enables scientists to systematically generate, examine, and prioritize high-confidence therapeutic hypotheses, ultimately advancing the field of drug development through innovative approaches grounded in human genetic research.

Novome Biotechnologies, Inc. is a biotechnology company based in South San Francisco, California, that specializes in engineering bacteria from the human gut to address chronic diseases. Founded in 2015, the company has developed a platform for the controlled colonization of the gut with genetically engineered bacteria, known as Genetically Engineered Microbial Medicines (GEMMs). This innovative approach allows for sustained therapeutic interventions through the precise delivery of microbial activities. Novome's lead preclinical program targets hyperoxaluria by creating a therapeutic strain of bacteria aimed at degrading oxalate to help prevent kidney stone formation. The company is also expanding its synthetic biology platform to explore additional therapeutic applications.

Evolv Technology specializes in noninvasive body scanners designed for touchless security screening, focusing on enhancing safety in public spaces. The company offers a range of products, including Evolv Express for firearm and bomb detection, Evolv Edge for checkpoint security, and Evolv Pinpoint for facial recognition. These systems are utilized in various settings, such as schools, stadiums, hospitals, and entertainment venues, to ensure the safety of employees, visitors, and VIPs. Founded in 2013 and headquartered in Waltham, Massachusetts, Evolv Technology aims to improve security protocols by integrating advanced sensors and artificial intelligence, enabling reliable scanning without compromising the visitor experience. The company has screened over 50 million individuals, successfully preventing more than 5,000 weapons from entering secure areas. With a leadership team comprising veterans from security agencies, Evolv is committed to providing effective solutions for both government and private sectors.

Novome Biotechnologies, Inc. is a biotechnology company based in South San Francisco, California, that specializes in engineering bacteria from the human gut to address chronic diseases. Founded in 2015, the company has developed a platform for the controlled colonization of the gut with genetically engineered bacteria, known as Genetically Engineered Microbial Medicines (GEMMs). This innovative approach allows for sustained therapeutic interventions through the precise delivery of microbial activities. Novome's lead preclinical program targets hyperoxaluria by creating a therapeutic strain of bacteria aimed at degrading oxalate to help prevent kidney stone formation. The company is also expanding its synthetic biology platform to explore additional therapeutic applications.

Novomer is a materials company focused on developing high-performance, eco-friendly plastics, polymers, and chemicals. Established in 2004 and based in Waltham, Massachusetts, the company leverages proprietary catalytic technology to convert carbon dioxide and other renewable materials into cost-effective industrial products. This innovative approach combines traditional chemical feedstocks with carbon, enabling the sustainable synthesis of a range of chemicals and materials. Novomer’s technology not only offers competitive pricing but also contributes to environmental sustainability by addressing global warming and climate change challenges through the use of carbon in industrial applications.